Corvus Pharmaceuticals, Inc. (CRVS)
18.76
-0.98
(-4.96%)
USD |
NASDAQ |
Feb 12, 16:00
18.73
-0.03
(-0.16%)
After-Hours: 04:34
Corvus Pharmaceuticals Cash from Investing (Quarterly) : -2.618M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Geron Corp. | 13.35M |
| Jaguar Health, Inc. | -0.054M |
| Krystal Biotech, Inc. | -4.286M |
| Rapt Therapeutics, Inc. | 8.466M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.566M |
| Cash from Financing (Quarterly) | 0.36M |
| Free Cash Flow | -32.22M |
| Free Cash Flow Per Share (Quarterly) | -0.1155 |
| Free Cash Flow to Equity (Quarterly) | -9.494M |
| Free Cash Flow to Firm (Quarterly) | -9.566M |
| Free Cash Flow Yield | -2.26% |